Impact of renal allograft histopathological findings on transplant patient outcomes and graft survival: A retrospective single-center study
Transplant Immunology · 2024
DOI: 10.1016/j.trim.2024.102142 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Transplant Immunology, 2024. Verfasst von Tiago Xavier Silva und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medical Sciences, Belo Horizonte, Minas Gerais, Brazil. Hauptthemen laut MEDLINE: Kidney Transplantation, Graft Survival, Graft Rejection. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: This study aimed to evaluate the reasons for kidney transplant dysfunction by analyzing allograft biopsy findings. We also compared clinical outcomes and graft survival rates in patients with and without de novo donor-specific antibodies (DSA). METHODS: This retrospective observational cohort study included 79 patients who underwent kidney allograft biopsy. The patients were divided into two groups based on the presence of anti-human leukocyte antigens (HLA) DSA antibodies. Laboratory evaluations included HLA-DSA and serum creatinine levels. The immunosuppressive therapy protocols were as follows: patients with single-antigen bead-measured sensitization (panel reactive antibody >50 %) received induction therapy, and all patients received triple therapy with tacrolimus or cyclosporine, prednisone, and mycophenolate sodium. RESULTS: Acute antibody-mediated rejection (AMR) occurred in 20.2 % of patients, whereas acute T-cell-mediated rejection (TCMR) was observed in 14 %. Interstitial fibrosis and tubular atrophy were observed in 53.8 % and 69.2 % of patients with de novo DSA, respectively, compared with 15.2 % and 87.9 % in the non-DSA group. Calcineurin inhibitors induced nephrotoxicity in 11.4 %, relapse of the underlying disease in 13.9 %, and infection in 7.6 % of biopsies. Differences in serum creatinine levels were observed between the de novo DSA and non-DSA groups from the third (p = 0.039), fifth (p = 0.028), and seventh years of follow-up (p = 0.012). The graft survival rate was lower in patients with de novo DSA than in those without (p = 0.036). CONCLUSIONS: TCMR and AMR were the most common findings. The occurrence of AMR significantly impacted renal function and graft survival, and patients with de novo anti-HLA antibodies had poorer outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medical Sciences, Belo Horizonte, Minas Gerais, Brazil.
- Faculty of the Hospital Santa Casa, Belo Horizonte, Minas Gerais, Brazil; IMUNOLAB - Laboratory of Histocompatibility, Belo Horizonte, Minas Gerais, Brazil. Electronic address: evaldo@imunolabtx.com.br.
- Faculty of Medical Sciences, Belo Horizonte, Minas Gerais, Brazil; IMUNOLAB - Laboratory of Histocompatibility, Belo Horizonte, Minas Gerais, Brazil. Electronic address: raquel.fabreti@cienciasmedicasmg.edu.br.
Zitieren
APA
Silva, T. X., Nascimento, E., de Oliveira, M. G., & Fabreti-Oliveira, R. A. (2024). Impact of renal allograft histopathological findings on transplant patient outcomes and graft survival: A retrospective single-center study. Transplant Immunology. https://doi.org/10.1016/j.trim.2024.102142
Vancouver
Silva TX, Nascimento E, de Oliveira MG, Fabreti-Oliveira RA. Impact of renal allograft histopathological findings on transplant patient outcomes and graft survival: A retrospective single-center study. Transplant Immunology. 2024. doi:10.1016/j.trim.2024.102142
BibTeX
@article{Silva2024,
author = {Silva, Tiago Xavier and Nascimento, Evaldo and de Oliveira, Marcelo Gonçalves and Fabreti-Oliveira, Raquel A},
title = {Impact of renal allograft histopathological findings on transplant patient outcomes and graft survival: A retrospective single-center study},
journal = {Transplant Immunology},
year = {2024},
doi = {10.1016/j.trim.2024.102142}
}
EUVIMED